British holiday company Thomas Cook said its chief executive Harriet Green was stepping down, two years after leading a turnaround of the group.» Read More
HONG KONG, June 6- Shares of Prada SpA fell more than 6 percent to a two-year-low on Friday after the Italian fashion house surprised investors with a drop in quarterly sales, sparking concern that the brand could be falling out of favour in key Asian markets.
June 5- Drug retailer Rite Aid Corp estimated first-quarter profit much below analysts' expectations due to higher-than-expected drug costs and a bigger-than-expected fall in reimbursement rates. Rite Aid's shares fell as much as 14 percent on Thursday on the New York Stock Exchange.
June 5- Truck and engine maker Navistar International Corp reported a smaller quarterly loss as warranty expenses fell and truck sales improved. Net loss attributable to Navistar narrowed to $297 million, or $3.65 per share, from $374 million, or $4.65 per share, a year earlier. Navistar's shares closed at $35.45 on the New York Stock Exchange on Wednesday.
June 5- Shares of Halozyme Therapeutics Inc jumped about 11 percent a day after the U.S. Food and Drug Administration lifted a hold on a trial testing an advanced version of the company's flagship drug delivery technology.
The value of potential takeovers yanked from the market is at its highest level since the height of the global credit crisis in 2008.
*FTSEurofirst 300 down 0.1 pct, Euro STOXX 50 down 0.1 pct. LONDON/ PARIS, June 4- European shares inched down on Wednesday after data confirmed a slowdown in the euro zone's economic recovery in the first quarter, with investors awaiting fresh action by the European Central Bank to spur growth.
*Steel shares outperform on Credit Suisse rating hikes. *Yahoo Japan jumps after Goldman Sachs adds to conviction list. Exporters were mixed, with Toyota Motor Corp rising 0.3 percent, while Honda Motor Co shed 0.5 percent and Toshiba Corp gained 0.7 percent.
*Expects 2nd- qtr adj profit/share $0.12- $0.13 vs est $0.21. *Expects revenue $250- $252 mln vs est $267.5 mln. Tibco, whose customers include Delta Air Lines Inc, FedEx Corp and Merck& Co Inc, estimated adjusted earnings of 12- 13 cents per share for the quarter ended June 1.
June 3- Discount retailer Dollar General Corp said it expects gross margins to improve in the second half of the year as it focuses on more profitable products such as accessories and stationery items priced at $1- $5. Dollar General shares rose as much as 5 percent on Tuesday.
There will likely be more food industry mergers in the months ahead, analysts say. Here's why.
Stocks on Wall Street were lower, following declines across Europe, but emerging market stocks rose, lifted in part by rising Brazilian and Mexican shares. MSCI's all-country world index of equity performance in 45 countries, fell 0.03 percent, while the pan-European FTSE Eurofirst 300 index of regional shares fell 0.4 percent to 1,374.98.
There is market rumor and speculation that Dublin-based, U.K.-listed pharma company Shire is a takeover target.
June 3- Pilgrim's Pride Corp, the second largest U.S. chicken processor, raised its offer for Hillshire Brands Co, escalating a bidding war with Tyson Foods Inc for the maker of Jimmy Dean sausages. Hillshire's shares rose 9 percent at $58.50 in premarket trading, after Pilgrim's Pride said it raised its offer to $55 per share in cash from $45.
June 2- Krispy Kreme Doughnuts Inc cut its adjusted earnings forecast for the full year as it expects a rise in costs related to technology upgrades and management changes, sending its shares down 9 percent in extended trading. The company cut its fiscal 2015 adjusted earnings forecast to 69- 74 cents per share from 73- 79 cents.
TORONTO, June 2- A major shareholder of Timmins Gold Corp, which owns the San Francisco gold mine in Mexico, said on Monday it planned to nominate six candidates for the company's eight-member board. Shares of Timmins jumped 5.8 percent to C $1.46 in morning trading on the Toronto Stock Exchange.
*Omeros shares jump 11 pct premarket. June 2- Omeros Corp said the U.S. Food and Drug Administration had approved its drug for use in cataract and lens replacement surgeries, the first drug developed by the company to get marketing clearance from the regulator.
June 2- Omeros Corp said the U.S. Food and Drug Administration had approved its drug for use in cataract and lens replacement surgeries, making it the company's first drug to be approved by the regulator. Omeros, whose shares were up 10 percent in premarket trading, said it plans to launch the drug, Omidria, later this year in the United States.
Apple's $3 billion acquisition of Beats is not a needle mover for the stock, but it makes sense, CNBC's Jim Cramer said.
Global companies paid out $228.4 billion in dividends in the first quarter this year, but Russian company dividends more than halved.
Kellogg shares are up roughly 10 percent this year amid speculation Buffett might acquire the company, but not everyone is sure it's a good idea.